Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-25 @ 4:26 AM
NCT ID:
NCT06648720
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18 years or older.
* Patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES).
* Patients with the following clinical indications for PCI:
* Unstable Angina: Prolonged chest pain at rest, new-onset angina within the past 2 months, or increasing frequency/severity of angina attacks.
* Acute Myocardial Infarction (MI): With or without ST-elevation.
* Chronic Coronary Syndrome: Requiring coronary revascularization.
* Patients who agree to participate and provide informed consent.
Exclusion Criteria:
* Inability to Provide Informed Consent: Patients who are unable or unwilling to provide consent.
* Neurological Complications: Stroke or any permanent neurological deficits within the last 3 months.
* Coronary Artery Bypass Graft Surgery: History of CABG surgery.
* Planned Surgery: Patients who have surgeries planned within the next 12 months.
* Severe Chronic Kidney Disease: Patients with an estimated glomerular filtration rate (eGFR) of less than 20 ml/min/1.73 m² or patients on dialysis.
* Chronic Anticoagulation Therapy: Patients requiring chronic oral anticoagulation (e.g., warfarin, DOACs) beyond DAPT.
* Thrombocytopenia: Platelet count less than 100,000/mm³.
* Contraindications to Antiplatelet Therapy: Allergy or intolerance to aspirin or P2Y12 inhibitors.
* Liver Disease: Patients with cirrhosis or significant liver dysfunction.
* Limited Life Expectancy: Patients with a life expectancy of less than 12 months due to other non-cardiac conditions.
* Other Medical Conditions: Any condition that might interfere with adherence to the study protocol or follow-up schedule.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06648720
Study Brief:
Protocol Section:
NCT06648720